Semi-Annual Balance Sheet

Oncolys BioPharma Inc. - Filing #7342826

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,532,844,000 JPY
1,711,280,000 JPY
Other
9,000 JPY
501,000 JPY
Current assets
1,955,883,000 JPY
2,608,754,000 JPY
Accounts receivable - other
51,781,000 JPY
174,310,000 JPY
Prepaid expenses
33,338,000 JPY
47,970,000 JPY
Non-current assets
Property, plant and equipment
JPY
JPY
Property, plant and equipment
Buildings
3,128,000 JPY
2,794,000 JPY
Accumulated depreciation
-3,128,000 JPY
-2,794,000 JPY
Buildings, net
JPY
JPY
Machinery and equipment
924,000 JPY
JPY
Accumulated depreciation
-924,000 JPY
JPY
Machinery and equipment, net
JPY
JPY
Tools, furniture and fixtures
66,967,000 JPY
65,939,000 JPY
Accumulated depreciation
-66,967,000 JPY
-65,939,000 JPY
Tools, furniture and fixtures, net
JPY
JPY
Investments and other assets
Shares of subsidiaries and associates
20,936,000 JPY
20,936,000 JPY
Investments and other assets
84,714,000 JPY
42,204,000 JPY
Investments in capital
100,000 JPY
100,000 JPY
Long-term loans receivable from subsidiaries and associates
42,549,000 JPY
JPY
Long-term prepaid expenses
135,000 JPY
JPY
Other
4,000 JPY
19,000 JPY
Non-current assets
84,714,000 JPY
42,204,000 JPY
Assets
2,040,598,000 JPY
2,650,959,000 JPY
Liabilities
Current liabilities
Short-term borrowings
127,776,000 JPY
227,776,000 JPY
Lease liabilities
7,565,000 JPY
3,581,000 JPY
Income taxes payable
18,844,000 JPY
2,931,000 JPY
Current liabilities
378,531,000 JPY
321,639,000 JPY
Accounts payable - other
193,354,000 JPY
60,858,000 JPY
Non-current liabilities
Non-current liabilities
187,969,000 JPY
170,051,000 JPY
Long-term borrowings
161,100,000 JPY
155,544,000 JPY
Lease liabilities
18,729,000 JPY
6,758,000 JPY
Liabilities
566,500,000 JPY
491,690,000 JPY
Other liabilities
Provision for retirement benefits
8,140,000 JPY
7,748,000 JPY
Other liabilities
Net assets
Share capital
3,623,165,000 JPY
3,000,000,000 JPY
Shareholders' equity
Capital surplus
Legal capital surplus
1,209,590,000 JPY
586,425,000 JPY
Capital surplus
1,209,590,000 JPY
586,425,000 JPY
Retained earnings
Other retained earnings
Retained earnings brought forward
-3,373,199,000 JPY
-1,434,694,000 JPY
Other retained earnings
Retained earnings
-3,373,199,000 JPY
-1,434,694,000 JPY
Treasury shares
-142,000 JPY
-142,000 JPY
Shareholders' equity
1,459,413,000 JPY
2,151,589,000 JPY
Net assets
14,683,000 JPY
3,623,165,000 JPY
1,474,097,000 JPY
-3,373,199,000 JPY
1,459,413,000 JPY
1,209,590,000 JPY
1,209,590,000 JPY
-142,000 JPY
-3,373,199,000 JPY
-1,434,694,000 JPY
-142,000 JPY
2,159,269,000 JPY
586,425,000 JPY
586,425,000 JPY
2,151,589,000 JPY
3,000,000,000 JPY
-1,434,694,000 JPY
JPY
7,680,000 JPY
7,680,000 JPY
-14,516,735,000 JPY
-113,000 JPY
3,593,992,000 JPY
9,039,516,000 JPY
-14,516,735,000 JPY
31,740,000 JPY
9,031,904,000 JPY
9,063,645,000 JPY
3,586,312,000 JPY
Share acquisition rights
14,683,000 JPY
7,680,000 JPY
Liabilities and net assets
2,040,598,000 JPY
2,650,959,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.